3Yang YM,Simon N,Maertens P,et al.Maternal-fetal transport of vitamin K1 and its effects on coagulation in premature infants[J].J Pediatr,1989,115 (6):1009-1013
4Danielsson N, Hoa DP, Thang NV, et al. Arch Dis Child Fetal Neonatal Ed, 2004,89 (6) : 546-550.
5Drazancic A. Antenatal care in developing countries - what should be done? J Peritnat Med, 2001, 29 (3): 188
6Moutquin JM, Milot Roy V, Zvion O. Preterm prevention: effectiveness of current strategies. J Soc Obste Gynaecol Can 1996; 18:571
7Jolly MM, Sebire J, Harris S et al. Obstetrics risk of pregnancy in women less than 18 years old . Obstetrics & Gynecology. 2000, 96(6): 962
8Silva AA, Simoes VM, Barbieri MA et al. Young maternal age and preterm brith. Pacdiatr Perinat Epidemiol. 2003, 17 (4):332
9Dulitzki M, Soriand D, Schief E et al. Effect of very advanced maternal age on pregnancy outcome and rate of cesarean delivery. Obstetrics & Gynecology. 1998, 92 (6): 935
10Kristensen J, Langhoff- Roos J. Implications of idiopathic preterm delivery for previous and subsequent pregnancies. Obstetrics & Gynecology. 1995, 86 (5): 800
7Douketis JD, Johnson JA, Turpie AG. Isow-molecular-weight heparin as bridging anticoagulation during interruption of warfarin : assessment of a standardized periprocedural anticoagulation regimen[J]. Arch In- tern Med, 2004,164(12) : 1319-1326.
8Cundiff DK. Clinical evidence for rebound hypercoagulability after discontinuing oral anticoagulants for venous thromboembolism[ J ]. Medscape J Med, 2008,10( 11 ) :258.
9Lee SO, Li M J, Ho HM, et al. Perioperative transient ischemic at- tack caused by the cessation of warfarin [ Jl. Acta Anaesthesiol Taiwan, 2010,48 (4) : 188-190.
10Carlqnist JF, Home BD, Mower C, et al. An evaluation of nine genetic variants related to nletabolism and mechanism of action of warfarin as applied to stable dose prediction[ J]. J Thromb Throm- bolysis, 2010,30( 3 ) :358-364.
